Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Predictive Oncology Featured in Broadcast Evaluating Targeted Cancer Therapies, Higher Survival Rates
NEW YORK , Nov. 07, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio –  Predictive Oncology (NASDAQ: POAI) announces the availability of a broadcast titled, “New Hope in the Battle Against Ovarian Cancer.” To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/L4Kxb To read the full
View HTML
Toggle Summary Predictive Oncology Featured in Publication Discussing the Impact of Artificial Intelligence on Cancer Treatment
NEW YORK , Nov. 06, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Predictive Oncology (NASDAQ: POAI) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities.
View HTML
Toggle Summary Predictive Oncology Reaches First Milestone in Building AI-driven Predictive Models of Ovarian Cancer
Helomics subsidiary begins sequencing retrospective ovarian cancer cases from UPMC-Magee collaboration, advancing POAI’s CancerQuest 2020 initiative MINNEAPOLIS , Oct. 31, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying
View HTML
Toggle Summary Predictive Oncology (NASDAQ: POAI) Featured in Broadcast on Big Data, AI’s Potential to Fight Cancer
NEW YORK , Oct. 31, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio –   Predictive Oncology (NASDAQ: POAI) announces the availability of a broadcast titled, “Delivering Precision Medicine’s True Potential: Big Data, Artificial Intelligence Identify New Cancer Therapeutics.” To hear the
View HTML
Toggle Summary Predictive Oncology (NASDAQ: POAI) Featured in NetworkNewsWire Publication Discussing Power of Data Plus AI in Precision Medicine
NEW YORK , Oct. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire —  Predictive Oncology (NASDAQ: POAI) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities.
View HTML
Toggle Summary Skyline Medical, a Division of Predictive Oncology Inc. (POAI), Sells 10 STREAMWAY® Systems to Prominent Teaching Hospital
  Skyline Medical, a subsidiary of POAI, continues to forge the standardization of waste fluid management with its sale of 10 systems in Rochester, NY .   The STREAMWAY System transforms the collection, measurement and disposal of healthcare waste fluid making it safer, easier and environmentally
View HTML
Toggle Summary Predictive Oncology Inc. Announces Pricing of Public Offering of Up to $3,167,768.50 of Common Stock
MINNEAPOLIS, Minn. , Oct. 02, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive” or “the Company”) today announced the pricing of its previously announced public offering of its common stock, with anticipated gross proceeds of up to $3,167,768.50 , before deducting
View HTML
Toggle Summary Predictive Oncology Inc. (POAI) Sells 10 STREAMWAY® Systems to Prominent Teaching Hospital
  Skyline Medical, a subsidiary of POAI, continues to forge the standardization of waste fluid management with its sale of 10 systems in Rochester, NY .   The STREAMWAY System transforms the collection, measurement and disposal of healthcare waste fluid making it safer, easier and environmentally
View HTML
Toggle Summary Predictive Oncology Inc. Announces Proposed Public Offering of Common Stock
MINNEAPOLIS , Oct. 01, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive” or “the Company”) today announced a proposed public offering of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the
View HTML
Toggle Summary Predictive Oncology Inc. Announces Repayment or Extension of Promissory Notes due September 28, 2019
MINNEAPOLIS , Sept. 30, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive” or “the Company”) today announced that its secured promissory notes that were due September 28, 2019 have been repaid or extended. On September 27, 2019 , the Company repaid the remaining
View HTML